Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
23,744 total articles
Draganfly Inc. has been selected as a qualified supplier across all five capability streams of Canada's Defence Drone Initiative Marketplace, enabling the company to engage in contract opportunities with Canadian Armed Forces and Coast Guard. This selection aligns Draganfly with Canada's $180 billion defense procurement investment over the next dec…
StablecoinX Inc., the Nasdaq-listed company focused on the Ethena digital dollar ecosystem, announced the appointment of Christopher Jensen as CEO and board director. Jensen, with extensive institutional investment and digital asset experience from Franklin Templeton, succeeds Ted Chen who remains chairman. Jensen will lead day-to-day operations ac…
Quoin Pharmaceuticals Ltd. announced the FDA has granted Rare Pediatric Disease (RPD) Designation for its lead drug candidate QRX003 for treating Peeling Skin Syndrome (PSS), marking its second RPD designation following one for Netherton Syndrome. This designation could enable Quoin to receive a Priority Review Voucher (PRV) with estimated market v…
Surrozen, Inc. has submitted an Investigational New Drug (IND) application for SZN-8141, a bifunctional antibody designed to treat diabetic macular edema by combining Wnt pathway activation and VEGF inhibition. This dual mechanism aims to reduce vascular leakage and promote retinal vascular integrity. Preclinical studies showed superior efficacy of…
PDS Biotechnology Corporation announced a private equity financing of up to $22.55 million led by Nant Capital, with Dr. Patrick Soon-Shiong joining as a board member. The funding will support late-stage clinical development of PDS0301, an immunocytokine targeting solid tumors, especially difficult-to-treat metastatic colorectal cancer. The transac…
CRISPR Therapeutics, a leader in gene-editing based biopharmaceuticals, announced a scheduled presentation at the Morgan Stanley 24th Annual Global Healthcare Conference. The company recently marked a historic milestone with the approval of CASGEVY®, the world's first CRISPR-based therapy, and continues to advance a robust pipeline across multiple …
Greenland Mines has entered a new strategic phase as a rare earths and critical minerals company after Nasdaq approved its transaction application, ensuring full compliance with listing requirements. The company recently closed the $2.05 billion high-case NPV Sarfartoq rare earth project acquisition, highlighting its focus on neodymium and praseody…
Dynagas LNG Partners LP announced its financial results for Q2 and H1 2026, reporting increased net income and steady fleet utilization of above 95%. The partnership highlights improved charter rates, reduced debt costs, and a healthy revenue backlog of $0.73 billion with an average contract term of 4.4 years. However, geopolitical tensions and evo…
Orion Energy Systems announced a significant follow-up order to deploy its high-efficiency MPHL2 LED Lighting system for a leading global data center operator, just three months after an initial multimillion-dollar deployment. This continued engagement underscores Orion’s growing role in the hyperscale data center market, driven by its energy-effic…
Can-Fite BioPharma announced Q2 2026 financial results alongside key clinical progress. The pivotal Phase III study in liver cancer showed longer-than-expected overall survival while maintaining a blinded status, prompting consideration for an earlier interim analysis. Positive durable survival outcomes were also observed in a Phase IIa pancreatic …
Veru Inc. announced positive preclinical data showing oral sabizabulin's potent anticancer activity against KRAS-driven metastatic pancreatic cancer cell lines resistant to FDA-approved daraxonrasib. Based on these results and prior clinical safety and efficacy data, the company plans to initiate a Phase 2b clinical trial for sabizabulin in patient…
Worthington Enterprises Inc. (NYSE: WOR) announced its fiscal first quarter 2027 earnings call scheduled for September 23, 2026. The company will release its quarterly financial results after market close on September 22, followed by a live webcast conference call. Worthington Enterprises operates in building products and consumer products sectors …
GRI Bio, Inc. announced new comprehensive Phase 2a clinical data for its oral drug candidate GRI-0621 in idiopathic pulmonary fibrosis (IPF). The study highlights nine mechanistic pillars supporting GRI-0621's action, including immune modulation, anti-fibrotic effects, basement membrane repair, and alveolar epithelial regeneration. Results also sho…
Phillips Edison & Company, Inc., a leading owner and operator of grocery-anchored shopping centers, announced that its CFO John Caulfield will participate in the Retail REIT Panel at the Barclays 24th Annual Global Financial Services Conference on September 14, 2026. The event will be webcast and a replay will be available on the company's investor…
MBX Biosciences, a Nasdaq-listed clinical-stage biopharmaceutical company, announced the appointment of Jeff Held as Chief Legal Officer. Held brings over 30 years of legal and executive experience in biotechnology and healthcare, having played key roles in financing, licensing, and company scale-ups. His leadership is expected to aid MBX's advance…
BioAge Labs has dosed the first participant in its Phase 2 QUELL-DME trial, evaluating the novel oral NLRP3 inhibitor BGE-102 for diabetic macular edema treatment. The trial, involving approximately 180 participants, assesses BGE-102 as monotherapy and in combination with anti-VEGF therapy, targeting improvements in visual acuity with topline resul…
Amwell (NYSE: AMWL) announced that the Department of Veterans Affairs (VA) has issued a Letter of Intent to deploy Amwell's virtual health platform across the VA enterprise to modernize its digital health infrastructure. The VA's selection follows a comprehensive evaluation highlighting Amwell's scalable video consultation capabilities, interoperab…
Anavex Life Sciences Corp., a Nasdaq-listed clinical-stage biopharmaceutical company focused on central nervous system diseases, announced an investor call to be held on September 9, 2026. The call, led by Interim CEO Terrie Kellmeyer, Ph.D., will outline the company's clinical development strategy and priorities. The announcement follows Anavex's …
MiMedx Group, Inc., a leader in wound care and healing solutions, announced that its senior management will participate in the Cantor Global Healthcare Conference and the Lake Street BIG10 Best Ideas Growth Conference to engage with investors and discuss company developments.
Avalyn Pharma announced its participation in the Morgan Stanley 24th Annual Global Healthcare Conference with a fireside chat presentation. The company is advancing inhaled formulations of antifibrotic medicines aimed at improving treatment for serious respiratory diseases such as pulmonary fibrosis. Avalyn is currently conducting Phase 2 trials fo…
Calidi Biotherapeutics, a biotechnology firm focused on targeted genetic medicines, announced its participation in the H.C. Wainwright 28th Annual Global Investment Conference. The company will present its RedTail platform and lead candidate CLD-401, aimed at treating metastatic cancers, particularly non-small cell lung cancer and head and neck can…
Niki BioSolutions, a clinical-stage life sciences company trading on NASDAQ under the ticker NIKI, announced its participation in the 28th Annual H.C. Wainwright Global Investment Conference. President and COO Alidad Mireskandari will present live and be available for meetings during the event. The company focuses on genomic and biomarker testing s…
Uniti Wholesale, a division of Uniti Group Inc., announced network expansions at the 1547 Critical Systems Realty data center in McAllen, Texas, and the H5 Data Center in Chandler, Arizona. These enhancements improve high-capacity 100G and 400G wave connectivity across critical U.S.-Mexico and Southwest corridors, supporting growth driven by hypers…
SINTX Technologies, a U.S.-based advanced ceramics and biomaterials company, announced participation at the 28th Annual H.C. Wainwright Global Investment Conference. The company will showcase its progress in commercializing its FDA-cleared SINAPTIC Foot & Ankle Implant System, expanding proprietary silicon nitride technology adoption, growing contr…
Liberty Global has agreed to sell VodafoneZiggo's Dutch tower assets for €669 million to a consortium of infrastructure funds. This move is part of Liberty Global's strategy to dispose of non-core assets valued between €1.2-1.4 billion to support the upcoming public listing of Ziggo Group in Amsterdam in mid-2027. Proceeds will be used to reduce de…
